Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Identification of potential drug targets for rheumatoid arthritis from genetic insights: a Mendelian randomization study

Submitted by Viola Mäkelä on Thu, 11/30/2023 - 13:23
  • Read more about Identification of potential drug targets for rheumatoid arthritis from genetic insights: a Mendelian randomization study

Causal Link between Gut Microbiota, Neurophysiological States, and Bone Diseases: A Comprehensive Mendelian Randomization Study

Submitted by Viola Mäkelä on Thu, 11/30/2023 - 13:20
  • Read more about Causal Link between Gut Microbiota, Neurophysiological States, and Bone Diseases: A Comprehensive Mendelian Randomization Study

Changes in the gut microbial profile during long-term androgen deprivation therapy for prostate cancer

Submitted by Viola Mäkelä on Thu, 11/30/2023 - 13:04
  • Read more about Changes in the gut microbial profile during long-term androgen deprivation therapy for prostate cancer

Detecting potential causal relationship between inflammatory bowel disease and rosacea using bi-directional Mendelian randomization

Submitted by Viola Mäkelä on Thu, 11/30/2023 - 11:17
  • Read more about Detecting potential causal relationship between inflammatory bowel disease and rosacea using bi-directional Mendelian randomization

Smoking, alcohol consumption and risk of Dupuytren’s disease: a Mendelian randomization study

Submitted by Viola Mäkelä on Thu, 11/30/2023 - 10:58
  • Read more about Smoking, alcohol consumption and risk of Dupuytren’s disease: a Mendelian randomization study

Causal Associations Between Gut Microbiota and Psoriasis: A Mendelian Randomization Study

Submitted by Viola Mäkelä on Thu, 11/30/2023 - 10:52
  • Read more about Causal Associations Between Gut Microbiota and Psoriasis: A Mendelian Randomization Study

Vitamin D Status, Vitamin D Receptor Polymorphisms, and the Risk of Incident Rosacea: Insights from Mendelian Randomization and Cohort Study in the UK Biobank

Submitted by Viola Mäkelä on Thu, 11/30/2023 - 10:43
  • Read more about Vitamin D Status, Vitamin D Receptor Polymorphisms, and the Risk of Incident Rosacea: Insights from Mendelian Randomization and Cohort Study in the UK Biobank

The role of NSAID in mediating the effect of genetically predicted major depressive disorder on osteomyelitis: A Mendelian randomization study

Submitted by Viola Mäkelä on Thu, 11/30/2023 - 10:31
  • Read more about The role of NSAID in mediating the effect of genetically predicted major depressive disorder on osteomyelitis: A Mendelian randomization study

Genetically Predicted Vegetable Intake and Cardiovascular Diseases and Risk Factors: An Investigation with Mendelian Randomization

Submitted by Viola Mäkelä on Thu, 11/30/2023 - 10:26
  • Read more about Genetically Predicted Vegetable Intake and Cardiovascular Diseases and Risk Factors: An Investigation with Mendelian Randomization

Causal relationship between endometriosis with infertility and ankylosing spondylitis

Submitted by Viola Mäkelä on Thu, 11/30/2023 - 10:23
  • Read more about Causal relationship between endometriosis with infertility and ankylosing spondylitis

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 370
  • Page 371
  • Page 372
  • Page 373
  • Current page 374
  • Page 375
  • Page 376
  • Page 377
  • Page 378
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social
Follow us on LinkedIn
https://www.linkedin.com/company/finngen/

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement